| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5648122 | Journal of the American Academy of Dermatology | 2017 | 11 Pages |
Abstract
Patients with psoriasis may experience an elevated risk of melanoma and hematologic cancers, compared with the general population. The risk is not increased by systemic or biologic psoriasis therapies.
Keywords
KPSCTNFiTNFpsoralen plus ultraviolet ACCIKaiser Permanente Southern CaliforniaRheumatoid arthritisUltravioletinterleukinmalignancyBiologicMelanomatopical therapyCharlson Comorbidity Indexconfidence intervaltumor necrosis factorPhototherapytumor necrosis factor inhibitorhazard ratioRate RatioPsoriasisPuva
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Shivani P. BS, Kathryn MD, Jashin J. MD,